Related references
Note: Only part of the references are listed.TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
Ricardo A. Chaurio et al.
IMMUNITY (2022)
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer
Aikun Fu et al.
CELL (2022)
Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection
Ryan Zander et al.
IMMUNITY (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Immunodynamics of explanted human tumors for immuno-oncology
Agathe Dubuisson et al.
EMBO MOLECULAR MEDICINE (2021)
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui et al.
CELL (2021)
Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
Abigail E. Overacre-Delgoffe et al.
IMMUNITY (2021)
IgA transcytosis and antigen recognition govern ovarian cancer immunity
Subir Biswas et al.
NATURE (2021)
Local induction of bladder Th1 responses to combat urinary tract infections
Jianxuan Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora et al.
NATURE (2021)
The microbiome and human cancer
Gregory D. Sepich-Poore et al.
SCIENCE (2021)
Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bladder cancer (MIBC): Results of the GETUG/AFU VESPER V05 phase III trial
C. Pfister et al.
ANNALS OF ONCOLOGY (2021)
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
Arjun Balar et al.
LANCET ONCOLOGY (2021)
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Paula Voabil et al.
NATURE MEDICINE (2021)
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
D. F. Bajorin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity
Gregory Noel et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
Bernadett Szabados et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Lower Airway Dysbiosis Affects Lung Cancer Progression
Jun-Chieh J. Tsay et al.
CANCER DISCOVERY (2021)
Fast identification of Escherichia coli in urinary tract infections using a virulence gene based PCR approach in a novel thermal cycler
Jolanda K. Brons et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2020)
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial
Alberto Briganti et al.
EUROPEAN UROLOGY (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer
Florence Marliot et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Maria Paula Roberti et al.
NATURE MEDICINE (2020)
Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle -invasive Bladder Cancer: A Call for Standardized Assessments and Definitions
Jared S. Winoker et al.
EUROPEAN UROLOGY FOCUS (2020)
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
Sangeeta Goswami et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
Nick van Dijk et al.
NATURE MEDICINE (2020)
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jianjun Gao et al.
NATURE MEDICINE (2020)
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Deciphering the Urinary Microbiota Repertoire by Culturomics Reveals Mostly Anaerobic Bacteria From the Gut
Gregory Dubourg et al.
FRONTIERS IN MICROBIOLOGY (2020)
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
Gonzalo Recondo et al.
NPJ PRECISION ONCOLOGY (2020)
Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
Eduard Ansaldo et al.
SCIENCE (2019)
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Daniel P. Hollern et al.
CELL (2019)
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles et al.
NATURE MEDICINE (2019)
Cancer Core Europe: A translational research infrastructure for a European mission on cancer
Alexander M. M. Eggermont et al.
MOLECULAR ONCOLOGY (2019)
T1 bladder cancer: current considerations for diagnosis and management
Brian Jordan et al.
NATURE REVIEWS UROLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang et al.
FASEB JOURNAL (2018)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Tobacco-smoking-related prevalence of methanogens in the oral fluid microbiota
Ghiles Grine et al.
SCIENTIFIC REPORTS (2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
Yien Ning Sophia Wong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Mo Xu et al.
NATURE (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2017)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V. Balar et al.
LANCET ONCOLOGY (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
The multiple antibacterial activities of the bladder epithelium
Jianxuan Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer
Chunyan Gu-Trantien et al.
JCI INSIGHT (2017)
The urinary microbiota: a paradigm shift for bladder disorders?
Linda Brubaker et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2016)
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillere et al.
IMMUNITY (2016)
Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry
Kathrin Moor et al.
NATURE PROTOCOLS (2016)
Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together
Gareth W. Jones et al.
FRONTIERS IN IMMUNOLOGY (2016)
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
Catherine Sautes-Fridman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Jacob H. Levine et al.
CELL (2015)
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2015)
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Ana L. Flores-Mireles et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
Giovanna Scapin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
Giovanna Scapin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
S. H. Vermeulen et al.
BRITISH JOURNAL OF CANCER (2015)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice
Mohammad Reza Asadi Karam et al.
VACCINE (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Urinary tract infections and reduced risk of bladder cancer in Los Angeles
X. Jiang et al.
BRITISH JOURNAL OF CANCER (2009)
Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry
Piseth Seng et al.
CLINICAL INFECTIOUS DISEASES (2009)
Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research
Lesley Graham et al.
NATURE PROTOCOLS (2007)
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection
MA Mulvey et al.
INFECTION AND IMMUNITY (2001)
Share Paper
